ESR1 and breast carcinoma: In the present study, we focus to determine the expression of SSTR2 and ORs and the changes in receptor expression and signaling pathways upon treatment with receptor specific agonist in human breast cancer cell lines; MCF-7 (ER + ve), MDA-MB231 (ER-ve), and T47D (ER + ve).